Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:drug |
| gptkbp:alternativeName |
V-9302
|
| gptkbp:CASNumber |
1446144-04-2
|
| gptkbp:chemicalFormula |
C19H18N4O2S
|
| gptkbp:clinicalTrialPhase |
preclinical
|
| gptkbp:developedBy |
gptkb:Vanderbilt_University
|
| gptkbp:hasInChIKey |
QZKQJQJQJQJQJQ-UHFFFAOYSA-N
|
| gptkbp:hasSMILES |
C1=CC=C(C=C1)C2=NC(=CS2)C(=O)NCC3=CC=CC=C3NC(=O)C4=CC=CC=N4
|
| https://www.w3.org/2000/01/rdf-schema#label |
NSS-806
|
| gptkbp:investigatedBy |
gptkb:cancer
gptkb:glioblastoma |
| gptkbp:mechanismOfAction |
ASCT2 inhibitor
|
| gptkbp:molecularWeight |
366.44 g/mol
|
| gptkbp:PubChem_CID |
CHEMBL4297597
71587761 |
| gptkbp:target |
SLC1A5 (ASCT2) transporter
|
| gptkbp:bfsParent |
gptkb:New_Skies
gptkb:Boeing_601 gptkb:HS-601_satellite_bus gptkb:NSS_satellites |
| gptkbp:bfsLayer |
7
|